Over the last 180 days, Corbus Pharmaceuticals Holdings, Inc. insiders sold a net $239.2K of stock across 75 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see 70 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | — | — | — | $0 |
| OPERATING INCOME | $-85.3M | $-48.7M | $-45.1M | $-39.8M |
| NET INCOME | $-78.5M | $-40.2M | $-44.6M | $-42.3M |
| EPS (DILUTED) | -5.90 | -3.68 | -10.31 | -10.15 |
| OPERATING CASH FLOW | $-64.5M | $-41.8M | $-36.1M | $-37.5M |
| CASH | $28.5M | $17.2M | $13.7M | $17.0M |
| LONG-TERM DEBT | — | — | $0 | $16.0M |
No password to create and no card required. We store your email address and nothing else.